# Enhertu

NDC: 65597-406
Generic name: fam-trastuzumab deruxtecan-nxki
Labeler / Manufacturer: Daiichi Sankyo Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20191220

FDA application: BLA761139

## Active ingredients

- TRASTUZUMAB DERUXTECAN: 100 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65597-406"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65597-406
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7e67e73e-ddf4-4e4d-8b50-09d7514910b6